Treatment schedules for 5-HT2A blocking in progressive multifocal leukoencephalopathy using risperidone or ziprasidone.

Article Details

Citation

Copy to clipboard

Kast RE, Focosi D, Petrini M, Altschuler EL

Treatment schedules for 5-HT2A blocking in progressive multifocal leukoencephalopathy using risperidone or ziprasidone.

Bone Marrow Transplant. 2007 Jun;39(12):811-2. Epub 2007 Apr 23.

PubMed ID

17450180 [ View in PubMed

]

Abstract

Not Available

DrugBank Data that Cites this Article

Drug Targets

Drug	Target	Kind	Organism	Pharmacological Action	Actions
Ziprasidone	5-hydroxytryptamine receptor 2A	Protein	Humans	Yes	Antagonist	Details